Production of laccase in a biocatalyst achieved 98.8% removal of ethinylestradiol in water, indicating effective estrogen biodegradation.
The widespread presence of estrogenic pollutants in aquatic environments poses a significant threat to ecosystems and human health, necessitating the development of efficient and sustainable removal technologies. This study aimed to develop a cost-effective biocatalyst for estrogen biodegradation using a fungal laccase. The enzyme was produced by the native strain Dichostereum sordulentum under semi-solid-state fermentation conditions optimized using a statistical Design of Experiments. The design evaluated carbon sources (glucose/glycerol), nitrogen sources (peptone/urea), inoculum size, and Eucalyptus dunnii bark as a solid support/substrate. The resulting laccase was entrapped within a hydrogel made of lignocellulosic biopolymers derived from a second-generation bioethanol by-product. Maximum laccase production was achieved with a high concentration of peptone (12 g/L), a low amount of bark (below 2.8 g), 8.5 g/L glucose and 300 mg/flask of inoculum. The subsequent immobilized laccase achieved 98.8 ± 0.5% removal of ethinylestradiol, outperforming the soluble enzyme. Furthermore, the treatment reduced the estrogenic biological activity by more than 170-fold. These findings demonstrate that the developed biocatalyst not only valorizes an industrial by-product but also represents an effective and sustainable platform for mitigating hazardous estrogenic pollution in water.
No takes yet. Share an insight, caveat, or question.
Vázquez et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: